The classes are designed to be inclusive in order to help people at all stages of the disease.
Trending
- Mechanisms and therapeutic targets in distant metastasis of lung adenocarcinoma
- Relapsed/Refractory Multiple Myeloma: Sequencing CAR T-Cell Therapy and Bispecific Antibodies
- Optimizing Surveillance Protocols After Focal Therapy for Prostate Cancer
- RASolute 302 and the Future of Pancreatic Cancer Treatment: Paul Oberstein, MD, on the KRAS Breakthrough
- Defining New Thresholds for Precisely Mitigating CAR T Toxicity
- DTX3 promotes anti-tumor immunity by inducing PD-L1 ubiquitination and is suppressed by p65/miR-222 in bladder cancer
- Reviewing the CheckMate 9DW Trial of Nivolumab Plus Ipilimumab in Unresectable HCC
- How to Speak With Patients About Potential Changes to Care During Biopsy Needle Delays

